RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE
Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY
Dr. Reddy's Laboratories Ltd RDY listed on NYSE and deals in Health Care Major PharmaceuticalsAnnouncements and dividends declared by Dr. Reddy's Laboratories Ltd RDY
India weight-loss market reset? In setback for Novo Nordisk, Dr Reddy's Lab allowed to make semaglutide
The order follows the court’s view that Novo Nordisk’s patent appears prima facie invalid -- a finding that could reshape competitive dynamics in a market valued at around Rs 850 crore.
Announcement as on 03 December 2025
HC lets Dr Reddy's Laboratories export Semaglutide, blocks India sales till March '26
The Delhi High Court has permitted Dr Reddy's Laboratories to produce and export its version of the diabetes and anti-obesity drug semaglutide. This decision comes amidst a patent infringement case filed by Novo Nordisk. Dr Reddy's is restricted from selli
Announcement as on 03 December 2025
Stocks in news: Dr Reddy's, GAIL, Hudco, HUL, Acme Solar
Indian markets experienced a subdued trading session, closing nearly half a percent lower due to global uncertainties and continued FII selling. With the monthly expiry approaching, volatility is expected to remain high. Investors are advised to maintain a
Announcement as on 25 November 2025
Dr Reddy's gets European nod for biosimilar to treat osteoporosis
Prolia is a prescription medicine used to treat osteoporosis in women who have been through menopause and in men who are at increased risk of fractures, bone loss linked to hormone ablation in men with prostate cancer at increased risk of fractures and bon
Announcement as on 24 November 2025
Dr Reddy’s gets EC nod for AVT03: New Prolia and Xgeva biosimilar set to launch across Europe
Dr. Reddy's Laboratories has secured European Commission marketing approval for AVT03, a biosimilar to Prolia and Xgeva, used for bone-related conditions. This authorization permits commercial launch across EU member states, Iceland, Liechtenstein, and Nor
Announcement as on 24 November 2025
Announcements by Dr. Reddy's Laboratories Ltd first page | Next page |
RDY Dr. Reddy's Laboratories Ltd current price & indicator signals
Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 05 Fri Dec 2025 | 14.19 | 14.10 to 14.21 | 0.35% | 0.86 times |
| 04 Thu Dec 2025 | 14.14 | 14.11 to 14.19 | 0.07% | 0.82 times |
| 03 Wed Dec 2025 | 14.13 | 14.08 to 14.17 | 0.21% | 0.65 times |
| 02 Tue Dec 2025 | 14.10 | 14.05 to 14.20 | 1.15% | 1.07 times |
| 01 Mon Dec 2025 | 13.94 | 13.94 to 14.06 | -0.78% | 1.13 times |
| 28 Fri Nov 2025 | 14.05 | 13.88 to 14.06 | 0.43% | 0.82 times |
| 26 Wed Nov 2025 | 13.99 | 13.88 to 13.99 | 0.79% | 1.08 times |
| 25 Tue Nov 2025 | 13.88 | 13.74 to 13.92 | 1.61% | 1.59 times |
| 24 Mon Nov 2025 | 13.66 | 13.64 to 13.85 | -1.8% | 1.18 times |
| 21 Fri Nov 2025 | 13.91 | 13.84 to 14.01 | 0.07% | 0.95 times |
| 20 Thu Nov 2025 | 13.90 | 13.89 to 14.08 | -1.07% | 0.72 times |
| 19 Wed Nov 2025 | 14.05 | 14.00 to 14.10 | 0.21% | 0.91 times |
Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE
Hindi Video Most Important Stock Market Video. No Success Without This Formula
Hindi Video What Is Needed To Succeed In Stock Markets
- NYSE Screeners
- NYSE Daily Screener
- NYSE Weekly Screener
- NYSE Monthly Screener
- Support & Resistance
- NYSE Shares Near Support
- NYSE Shares Near Resistance


